Are you Dr. Klein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6345 Gray Sea Way
Columbia, MD 21045Phone+1 503-419-7291
Summary
- Dr. Eran Klein, MD is a board certified neurologist in Columbia, Maryland. He is currently licensed to practice medicine in Maryland and Oregon. He is affiliated with Portland HCS and is an Instructor at Oregon Health and Science University School of Medicine.
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Neurology, 2004 - 2008
- Georgetown University School of MedicineClass of 2004
Certifications & Licensure
- OR State Medical License 2010 - 2025
- MD State Medical License 2008 - 2010
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Dual Treatment of Refractory Focal Epilepsy and Obsessive-Compulsive Disorder With Intracranial Responsive Neurostimulation.Marissa A Kellogg, Lia D Ernst, David C Spencer, Proleta Datta, Eran Klein
Neurology. Clinical Practice. 2024-08-01 - 2 citationsEthical, legal, and policy challenges in field-based neuroimaging research using emerging portable MRI technologies: guidance for investigators and for oversight.Francis X Shen, Susan M Wolf, Frances Lawrenz, Donnella S Comeau, Kafui Dzirasa
Journal of Law and the Biosciences. 2024-06-07 - 6 citationsEthical issues raised by incorporating personalized language models into brain-computer interface communication technologies: a qualitative study of individuals with n...Eran Klein, Michelle Kinsella, Ian Stevens, Melanie Fried-Oken
Disability and Rehabilitation. Assistive Technology. 2024-04-01
Press Mentions
- UW-Led Philosophy Team Receives $1.5M Grant to Study the Ethics of Neurotechnology ResearchNovember 28th, 2018
- A Death and Other Adverse Events in French Drug Trial Raise Questions About Testing Safety and EthicsDecember 8th, 2016
- A Death and Other Adverse Events in French Drug Trial Raise Questions About Testing Safety and EthicsDecember 8th, 2016
- Join now to see all
Professional Memberships
- Member